$0.6419
0.034.10%
At close: -
$0.6066
-0.04-5.50%
After Hours: 9:26 AM EDT
Comments
Loading...
Jin Medical International Earnings Estimates, EPS & Revenue | NASDAQ:ZJYL | Benzinga
Jin Medical International reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Jul 26
EPS
$0.010
Quarterly Revenue
$10.56M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$23.50M
Analyze the earnings history of Jin Medical International using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ZJYL | Jin Medical International | $0.02 | — | — | — | $19.82M | — | — | — | 05/03/2025 | Get Alert |
| ZJYL | Jin Medical International | $0.01 | — | $0.01 | — | $10.25M | — | $10.56M | — | 07/26/2024 | Get Alert |
| ZJYL | Jin Medical International | $0.02 | — | $0.02 | — | $19.19M | — | $19.82M | — | 04/26/2024 | Get Alert |
| ZJYL | Jin Medical International | $0.01 | — | $0.01 | — | $9.47M | — | $10.25M | — | 08/23/2023 | Get Alert |
Jin Medical International (ZJYL) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
Jin Medical International (ZJYL) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Jin Medical International (NASDAQ:ZJYL) reporting earnings?
Jin Medical International (ZJYL) is scheduled to report earnings on May 3, 2025. The last reported earnings were for reported on July 26, 2024 for H1.
What were the latest earnings per share (EPS) for Jin Medical International (NASDAQ:ZJYL)?
The Actual EPS was $0.01, which beat the estimate of $0.00.
What were Jin Medical International’s (NASDAQ:ZJYL) revenues?
The Actual Revenue was $10.6M, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.